<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Detection of Epstein-Barr virus (EBV) DNA in the cerebrospinal fluid (CSF) is associated with acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>)-related brain <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Real-time polymerase chain reaction (PCR) was performed to quantify EBV DNA in CSF and plasma from 42 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-related non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) </plain></SENT>
<SENT sid="2" pm="."><plain>Twenty patients had primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (PCNSL) and 22 systemic NHL, including 12 with central <z:mp ids='MP_0008912'>nervous</z:mp> system involvement (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-NHL) </plain></SENT>
<SENT sid="3" pm="."><plain>As controls, 16 HIV-infected patients with other <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> disorders were examined </plain></SENT>
<SENT sid="4" pm="."><plain>EBV DNA was detected in the CSF from 16/20 (80%) patients with PCNSL, 7/22 (32%) with systemic NHL, 8/12 (67%) with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-NHL, and 2/16 (13%) of the controls </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:mp ids='MP_0001799'>viral</z:mp> EBV DNA levels were significantly higher in the CSF from patients with PCNSL or <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-NHL compared to patients with systemic NHL or controls </plain></SENT>
<SENT sid="6" pm="."><plain>EBV DNA was detected in plasma from 5/16 (31%) patients with PCNSL, 9/16 (56%) with systemic NHL, 4/9 (44%) with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-NHL, and 4/15 (27%) controls </plain></SENT>
<SENT sid="7" pm="."><plain>No difference in plasma <z:mp ids='MP_0001799'>viral</z:mp> load was found between patient groups </plain></SENT>
<SENT sid="8" pm="."><plain>From the patients with <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>-NHL, plasma samples drawn prior to <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement contained significantly higher EBV DNA levels than those from systemic NHL patients without subsequent <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement </plain></SENT>
<SENT sid="9" pm="."><plain>EBV DNA levels in the CSF, but not in plasma, from patients treated with antiherpes drugs were significantly lower than in untreated patients </plain></SENT>
<SENT sid="10" pm="."><plain>High CSF EBV DNA levels were found in HIV-associated brain <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and the <z:mp ids='MP_0001799'>viral</z:mp> load can be clinically useful </plain></SENT>
<SENT sid="11" pm="."><plain>High plasma EBV DNA levels might predict <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> involvement in systemic NHL </plain></SENT>
</text></document>